In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...

A constitutional challenge to the Biden administration program enabling Medicare to negotiate lower prices for prescription drugs has been revived by a federal appeals court ...

A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...

A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...

Parents pushed for years for treatments for the neuron disease Niemann-Pick type C. After setbacks, one drug now has FDA ...

Scientists have devised a free AI algorithm that they believe will make finding new medicines far more efficient.

The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...

Utah's life sciences sector is a significant economic powerhouse, but the misguided the Medication Affordability and Patent ...

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.

Wockhardt's investigational drug WCK 5222, Zaynich, has shown promising results in treating drug-resistant meningitis, with a patient reportedly cured within three weeks, said Chairman Habil F ...

Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.